![Alastair MacKinnon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alastair MacKinnon
Amministratore Delegato presso
Dark Blue Therapeutics Ltd.
Profilo
Alastair Graham MacKinnon was the founder of Mereo BioPharma Group Plc, founded in 2015, where the title held was Chief Portfolio Management & Pipeline Strategy from 2021 to 2022.
Current jobs include Chief Executive Officer & Director at Dark Blue Therapeutics Ltd. since 2022; Director at Mereo BioPharma 3 Ltd., Mereo BioPharma 2 Ltd. since 2015, and Mereo BioPharma 4 Ltd. since 2017; and Member at The Royal College of Surgeons of Edinburgh.
Former job includes Partner at Phase4 Partners Ltd. from 2014 to 2022.
Education includes undergraduate and doctorate degrees from King's College London.
Posizioni attive di Alastair MacKinnon
| Società | Posizione | Inizio |
|---|---|---|
The Royal College of Surgeons of Edinburgh
 The Royal College of Surgeons of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Mereo Biopharma 3 Ltd.
 Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Direttore/Membro del Consiglio | - |
Mereo BioPharma 2 Ltd.
 Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Direttore/Membro del Consiglio | 30/06/2015 |
Mereo BioPharma 4 Ltd.
 Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Direttore/Membro del Consiglio | 24/10/2017 |
Dark Blue Therapeutics Ltd.
 Dark Blue Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops precision oncology medicines | Amministratore Delegato | 01/08/2022 |
Precedenti posizioni note di Alastair MacKinnon
| Società | Posizione | Fine |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Fondatore | 01/08/2022 |
Phase4 Partners Ltd.
 Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Investitore di Private Equity | 28/02/2022 |
Formazione di Alastair MacKinnon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
55
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million. | Finance |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Surgeons of Edinburgh
The Royal College of Surgeons of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Mereo Biopharma 3 Ltd.
Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products | Health Technology |
Mereo BioPharma 2 Ltd.
Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology | Commercial Services |
Mereo BioPharma 4 Ltd.
Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services | Commercial Services |
Dark Blue Therapeutics Ltd.
Dark Blue Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops precision oncology medicines | Health Technology |
